DK634689A - Anvendelse af castanospermin-estere eller deres salte til fremstilling af laegemidler, der inhiberer tumor-metastaser - Google Patents

Anvendelse af castanospermin-estere eller deres salte til fremstilling af laegemidler, der inhiberer tumor-metastaser Download PDF

Info

Publication number
DK634689A
DK634689A DK634689A DK634689A DK634689A DK 634689 A DK634689 A DK 634689A DK 634689 A DK634689 A DK 634689A DK 634689 A DK634689 A DK 634689A DK 634689 A DK634689 A DK 634689A
Authority
DK
Denmark
Prior art keywords
esters
salts
castanospermin
preparation
tumor metastases
Prior art date
Application number
DK634689A
Other languages
Danish (da)
English (en)
Other versions
DK634689D0 (da
Inventor
Sai Prasad Sunkara
Paul Saiho Liu
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK634689D0 publication Critical patent/DK634689D0/da
Publication of DK634689A publication Critical patent/DK634689A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK634689A 1988-12-15 1989-12-14 Anvendelse af castanospermin-estere eller deres salte til fremstilling af laegemidler, der inhiberer tumor-metastaser DK634689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/284,510 US4952585A (en) 1988-12-15 1988-12-15 Castanospermine esters in the inhibition of tumor metastasis

Publications (2)

Publication Number Publication Date
DK634689D0 DK634689D0 (da) 1989-12-14
DK634689A true DK634689A (da) 1990-06-16

Family

ID=23090466

Family Applications (1)

Application Number Title Priority Date Filing Date
DK634689A DK634689A (da) 1988-12-15 1989-12-14 Anvendelse af castanospermin-estere eller deres salte til fremstilling af laegemidler, der inhiberer tumor-metastaser

Country Status (12)

Country Link
US (1) US4952585A (de)
EP (1) EP0373663B1 (de)
JP (1) JP2963476B2 (de)
KR (1) KR0135278B1 (de)
AT (1) ATE96320T1 (de)
AU (1) AU621431B2 (de)
DE (1) DE68910287T2 (de)
DK (1) DK634689A (de)
ES (1) ES2061912T3 (de)
IE (1) IE62014B1 (de)
PH (1) PH26024A (de)
ZA (1) ZA899451B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US4970317A (en) * 1989-08-08 1990-11-13 Merrell Dow Pharmaceuticals Inc. Process for the preparation of castanospermine esters
CA2287316C (en) * 1997-05-22 2005-02-08 Hoechst Marion Roussel, Inc. Process for preparing 6-o-monoesters of castanospermine
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
US6013459A (en) * 1997-06-12 2000-01-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
US8226684B2 (en) * 2008-12-22 2012-07-24 Ethicon, Inc. Surgical sutures having collapsible tissue anchoring protrusions and methods therefor
US8703744B2 (en) * 2009-03-27 2014-04-22 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
WO2017138008A2 (en) * 2016-02-14 2017-08-17 Yeda Research And Development Co. Ltd. Methods of modulating protein exocytosis and uses of same in therapy
WO2018059214A1 (zh) 2016-09-29 2018-04-05 广州君赫生物科技有限公司 影响saicar合成的化合物及应用
US11684593B2 (en) 2017-04-20 2023-06-27 Geneheal Biotechnology Co., Ltd. Applications of spermine and its derivative in preparation of antitumor drug
CA3064486C (en) 2017-04-20 2023-08-01 Geneheal Biotechnology Co., Ltd. Applications of spermidine and its derivatives
US12605349B2 (en) 2024-09-05 2026-04-21 Orbus Therapeutics, Inc. Methods of treating grade 3 astrocytoma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792558A (en) * 1987-05-29 1988-12-20 Merrell Dow Pharmaceuticals Inc. Castanospermine for inhibiting tumor metastasis
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
AU618838B2 (en) * 1988-08-10 1992-01-09 Praxis Pharmaceuticals, Inc. Use of castanospermine as an anti-inflammatory and immunosuppressant agent

Also Published As

Publication number Publication date
DE68910287T2 (de) 1994-03-10
AU621431B2 (en) 1992-03-12
IE894009L (en) 1990-06-15
DK634689D0 (da) 1989-12-14
ES2061912T3 (es) 1994-12-16
EP0373663A2 (de) 1990-06-20
AU4670789A (en) 1990-06-21
EP0373663B1 (de) 1993-10-27
JP2963476B2 (ja) 1999-10-18
EP0373663A3 (en) 1990-09-12
US4952585A (en) 1990-08-28
KR0135278B1 (ko) 1998-04-23
IE62014B1 (en) 1994-12-14
JPH02212427A (ja) 1990-08-23
PH26024A (en) 1992-01-24
KR910011256A (ko) 1991-08-07
ATE96320T1 (de) 1993-11-15
ZA899451B (en) 1990-09-26
DE68910287D1 (de) 1993-12-02

Similar Documents

Publication Publication Date Title
DK634689D0 (da) Anvendelse af castanospermin-estere eller deres salte til fremstilling af laegemidler, der inhiberer tumor-metastaser
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
DK146482A (da) Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK215887A (da) Farmaceutisk praeparat af omeprazol til oral ind- gift
NO163816C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive piperazinderivater.
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
DK164917C (da) Analogifremgangsmaade til fremstilling af bicyklisk substituerede dipeptidderivater og deres farmaceutisk acceptable salte
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO893270L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
DK430288A (da) 1,4-dihydropyridinderivater, fremgangsmaade til fremstilling af saadanne derivater og laegemiddel indeholdende disse
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
NO172490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO168108C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive adeninderivater
DK689188D0 (da) Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
DK707988A (da) Fremgangsmaade til at haemme virus

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment